Proteasome 26S subunit PSMD1 regulates breast cancer cell growth through p53 protein degradation

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of Biochemistry (Tokyo)

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/jb/mvx053PMID 28992264
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Proteasome inhibitors in cancer therapy: Treatment regimen and peripheral neuropathy as a side effect

  2017cited by this paper
• Proteasome inhibitors in cancer therapy

  2017cited by this paper
• Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer

  2016cited by this paper
• ATP5A1 and ATP5B are highly expressed in glioblastoma tumor cells and endothelial cells of microvascular proliferation

  2016cited by this paper
• Factors Promoting Tamoxifen Resistance in Breast Cancer via Stimulating Breast Cancer Stem Cell Expansion.

  2015cited by this paper
• p53: Protection against Tumor Growth beyond Effects on Cell Cycle and Apoptosis.

  2015cited by this paper
• MicroRNA-574-3p, identified by microRNA library-based functional screening, modulates tamoxifen response in breast cancer

  2015cited by this paper
• Chymotrypsin-like activity and subunit composition of proteasomes in human cancers

  2014cited by this paper
• The ribosomal protein S26 regulates p53 activity in response to DNA damage

  2014cited by this paper
• TSPAN12 is a critical factor for cancer–fibroblast cell contact-mediated cancer invasion

  2014cited by this paper
• Is oestrogen an important player in melanoma progression?

  2014cited by this paper
• Short Hairpin RNA Library-Based Functional Screening Identified Ribosomal Protein L31 That Modulates Prostate Cancer Cell Growth via p53 Pathway

  2014cited by this paper
• Tetraspanin TSPAN12 regulates tumor growth and metastasis and inhibits β-catenin degradation

  2014cited by this paper
• RNA Sequencing of MCF-7 Breast Cancer Cells Identifies Novel Estrogen-Responsive Genes with Functional Estrogen Receptor-Binding Sites in the Vicinity of Their Transcription Start Sites

  2013cited by this paper
• Ribosomal protein S14 unties the MDM2–p53 loop upon ribosomal stress

  2013cited by this paper
• miR‐493 induction during carcinogenesis blocks metastatic settlement of colon cancer cells in liver

  2012cited by this paper
• Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.

  2012cited by this paper
• Modulators of Prostate Cancer Cell Proliferation and Viability Identified by Short-Hairpin RNA Library Screening

  2012cited by this paper
• Forkhead box transcription factor, forkhead box A1, shows negative association with lymph node status in endometrial cancer, and represses cell proliferation and migration of endometrial cancer cells

  2012cited by this paper
• Integration of cap analysis of gene expression and chromatin immunoprecipitation analysis on array reveals genome-wide androgen receptor signaling in prostate cancer cells

  2011cited by this paper
• Proteasome inhibitors in cancer therapy

  2011cited by this paper
• An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients

  2010cited by this paper
• Silencing of Ribosomal Protein S9 Elicits a Multitude of Cellular Responses Inhibiting the Growth of Cancer Cells Subsequent to p53 Activation

  2010cited by this paper
• Functional screening using a microRNA virus library and microarrays: a new high-throughput assay to identify tumor-suppressive microRNAs.

  2010cited by this paper
• Knockdown of Efp by DNA-modified small interfering RNA inhibits breast cancer cell proliferation and in vivo tumor growth

  2010cited by this paper
• Increased proteasome subunit protein expression and proteasome activity in colon cancer relate to an enhanced activation of nuclear factor E2-related factor 2 (Nrf2)

  2009cited by this paper
• Combination of Proteasome and HDAC Inhibitors for Uterine Cervical Cancer Treatment

  2009cited by this paper
• Knockdown of Efp by DNA-modified small interfering RNA inhibits breast cancer cell proliferation and in vivo tumor growth

  2009cited by this paper
• The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells

  2009cited by this paper
• The putative tumour modifier gene ATP5A1 is not mutated in human colorectal cancer cell lines but expression levels correlate with TP53 mutations and chromosomal instability

  2009cited by this paper
• Identification of TACC1, NOV, and PTTG1 as new candidate genes associated with endocrine therapy resistance in breast cancer.

  2008cited by this paper
• Crosstalk between the estrogen receptor and the HER tyrosine kinase receptor family: molecular mechanism and clinical implications for endocrine therapy resistance.

  2008cited by this paper
• Diminished feedback regulation of proteasome expression and resistance to proteasome inhibitors in breast cancer cells

  2007cited by this paper
• Lessons learned from DNA repair defective syndromes

  2007cited by this paper
• Over-expression of genes and proteins of ubiquitin specific peptidases (USPs) and proteasome subunits (PSs) in breast cancer tissue observed by the methods of RFDD-PCR and proteomics

  2007cited by this paper
• Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles.

  2007cited by this paper
• Ovarian cancers overexpress the antimicrobial protein hCAP‐18 and its derivative LL‐37 increases ovarian cancer cell proliferation and invasion

  2007cited by this paper
• Increased proteasome activity, ubiquitin-conjugating enzymes, and eEF1A translation factor detected in breast cancer tissue.

  2005cited by this paper
• The biological role of estrogen receptors α and β in cancer

  2004cited by this paper
• The biological role of estrogen receptors alpha and beta in cancer.

  2004cited by this paper
• A phase 2 study of bortezomib in relapsed, refractory myeloma.

  2003cited by this paper
• Human securin interacts with p53 and modulates p53-mediated transcriptional activity and apoptosis

  2002cited by this paper
• p53 Signaling and cell cycle checkpoints.

  2001influential reference
• Proteasome inhibitors: a novel class of potent and effective antitumor agents.

  1999cited by this paper
• Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis.

  1999cited by this paper
• Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

  1998cited by this paper
• The Proteasome : Paradigm Review of a Self-Compartmentalizing Protease and unfolding

  1998cited by this paper
• Tamoxifen for early breast cancer: an overview of the randomised trials

  1998cited by this paper
• The proteasome: paradigm of a self-compartmentalizing protease.

  1998cited by this paper
• Regulation of p53 stability by Mdm2

  1997cited by this paper
• Mdm2 promotes the rapid degradation of p53

  1997cited by this paper
• Structure and functions of the 20S and 26S proteasomes.

  1996cited by this paper

• PSMD1 inhibition suppresses tumor progression and enhances antitumor immunity by modulating the RTKN/β-catenin/PD-L1 axis in hepatocellular carcinoma

  2026cites this paper
• GOLM1 promotes prostate cancer progression via interaction with PSMD1 and enhancing AR‐driven transcriptional activation

  2024cites this paper
• Depletion of proteasome subunit PSMD1 induces cancer cell death via protein ubiquitination and DNA damage, irrespective of p53 status

  2024influential citation
• Molecular subtype identification and prognosis stratification based on lysosome-related genes in breast cancer

  2024cites this paper
• PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation

  2023cites this paper
• The prognostic value of 19S ATPase proteasome subunits in acute myeloid leukemia and other forms of cancer

  2023cites this paper
• PSMD1 as a prognostic marker and potential target in oropharyngeal cancer

  2023cites this paper
• Novel disulfidptosis‐derived gene blueprint stratifying patients with breast cancer

  2023cites this paper
• Analysis and experimental validation of the innate immune gene PSMD1 in liver hepatocellular carcinoma and pan-cancer

  2023cites this paper
• Proteasome 26S subunit, non-ATPase 1 (PSMD1) facilitated the progression of lung adenocarcinoma by the de-ubiquitination and stability of PTEN-induced kinase 1 (PINK1).

  2022cites this paper
• Transcriptomics, molecular docking, and cross-resistance profiling of nobiletin in cancer cells and synergistic interaction with doxorubicin upon SOX5 transfection.

  2022cites this paper
• A Ubiquitin-Proteasome Gene Signature for Predicting Prognosis in Patients With Lung Adenocarcinoma

  2022cites this paper
• Prognostic Implication and Immunological Role of PSMD2 in Lung Adenocarcinoma

  2022cites this paper
• Genome-wide association study for systemic lupus erythematosus in an egyptian population

  2022cites this paper
• PRRX2 predicts poor survival prognosis, and promotes malignant phenotype of lung adenocarcinoma via transcriptional activates PSMD1

  2022cites this paper
• Identification and validation of immune and prognosis-related genes in hepatocellular carcinoma: A review

  2022cites this paper
• 19S Proteasome Subunits as Oncogenes and Prognostic Biomarkers in FLT3-Mutated Acute Myeloid Leukemia (AML)

  2022cites this paper
• Prognostic and immune infiltration signatures of proteasome 26S subunit, non-ATPase (PSMD) family genes in breast cancer patients

  2021cites this paper
• Ring finger protein 152-dependent degradation of TSPAN12 suppresses hepatocellular carcinoma progression

  2021cites this paper
• Proteasome 26S subunit, non-ATPases 1 (PSMD1) and 3 (PSMD3), play an oncogenic role in chronic myeloid leukemia by stabilizing nuclear factor-kappa B

  2021influential citation
• Protein Aggregation Patterns Inform about Breast Cancer Response to Antiestrogens and Reveal the RNA Ligase RTCB as Mediator of Acquired Tamoxifen Resistance

  2021cites this paper
• Research progress on proteasome subunits in regulating occurrence and development of hepatocellular carcinoma.

  2021cites this paper
• Role of Sulfur Metabolism Gene and High-Sulfur Gene Expression in Wool Growth Regulation in the Cashmere Goat

  2021cites this paper
• 26S Proteasome Non-ATPase Regulatory Subunits 1 (PSMD1) and 3 (PSMD3) as Putative Targets for Cancer Prognosis and Therapy

  2021cites this paper
• Contralateral parenchymal enhancement on MRI is associated with tumor proteasome pathway gene expression and overall survival of early ER+/HER2-breast cancer patients

  2021cites this paper
• CRISPR-based gene knockout screens reveal deubiquitinases involved in HIV-1 latency in two Jurkat cell models

  2020cites this paper
• PSMD12 promotes breast cancer growth via inhibiting the expression of pro-apoptotic genes.

  2020cites this paper
• PSMD1 and PSMD2 regulate HepG2 cell proliferation and apoptosis via modulating cellular lipid droplet metabolism

  2019cites this paper
• The RNA polymerase III repressor MAF1 is regulated by ubiquitin-dependent proteasome degradation and modulates cancer drug resistance and apoptosis

  2019cites this paper
• Proteasomes and Several Aspects of Their Heterogeneity Relevant to Cancer

  2019cites this paper
• Prognostic Significance of PSMD1 Expression in Patients with Gastric Cancer

  2019influential citation
• PM2.5-induced alteration of DNA methylation and RNA-transcription are associated with inflammatory response and lung injury.

  2019cites this paper
• Analysis of the Antiproliferative Effect of Ankaferd Hemostat on Caco-2 Colon Cancer Cells via LC/MS Shotgun Proteomics Approach

  2019cites this paper
• The Expression and Prognostic Significance of the Nicotinic Receptor Cluster on 15q25 about CHRNA5 and PSMA4 mRNA in Lung Adenocarcinoma Utilizing TCGA Datasets

  2019cites this paper